Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 23
Phase 31

Trial Status

Completed1
Terminated1
Other1

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT02991898Phase 2Terminated
Adoptive TReg Cell for Suppression of aGVHD After UCB HSCT for Heme Malignancies
Acute Lymphoblastic LeukemiaAcute Myelogenous LeukemiaBiphenotypic Leukemia+15 more
PrincipalinvestigatorStart date: 2017-02-16
NCT00177047Phase 2/3Completed
Autologous Transplant for Multiple Myeloma
Multiple Myeloma
PrincipalinvestigatorStart date: 2004-04-20
NCT01163201Phase 1/2Withdrawn
T-Regulatory Cell and CD3 Depleted Double Umbilical Cord Blood Transplantation in Hematologic Malignancies
Acute Lymphocytic LeukemiaAcute Myeloid LeukemiaAnemia, Refractory, With Excess of Blasts+14 more
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Related
24 trials

Shared therapeutic areas:

Multiple MyelomaLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphoma, Follicular+5 more
Similarity Score10%

Yves Beguin, MD, PhD

CHU-ULg

Related
7 trials

Shared therapeutic areas:

Hematologic NeoplasmsHodgkin DiseasePrecursor Cell Lymphoblastic Leukemia-Lymphoma+5 more
Similarity Score10%

Arnon Nagler, MD

Chaim Sheba Medical Center

Related
12 trials

Shared therapeutic areas:

Hodgkin DiseaseMultiple MyelomaLeukemia, Myeloid, Acute+4 more
Similarity Score9%

David Avigan, MD

Beth Israel Deaconess Medical Center

Related
17 trials

Shared therapeutic areas:

Multiple MyelomaLeukemia, Myeloid, AcuteHodgkin Disease+3 more
Similarity Score8%

Jorge Cortes, MD

M.D. Anderson Cancer Center

Related
24 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMyelodysplastic Syndromes+2 more
Similarity Score6%

Qifa Liu

Nanfang Hospital, Southern Medical University

Related
33 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteMyelodysplastic SyndromesHematologic Neoplasms+2 more
Similarity Score6%

Beata Holkova, MD

Massey Cancer Center

Related
3 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL Positive+1 more
Similarity Score5%

Jae Park, MD

Memorial Sloan Kettering Cancer Center

Related
17 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Lymphocytic, Chronic, B-CellLeukemia, Myeloid, Acute+1 more
Similarity Score5%

Areej El-Jawahri, MD

Massachusetts General Hospital

Related
21 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteHematologic NeoplasmsMultiple Myeloma+1 more
Similarity Score5%

Michael B Gill

Power Life Sciences Inc.

Related
105 trials

Shared therapeutic areas:

Leukemia, Lymphocytic, Chronic, B-CellLymphoma, FollicularLymphoma, Mantle-Cell+1 more
Similarity Score5%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT02991898Phase 2PrincipalInvestigator

Adoptive TReg Cell for Suppression of aGVHD After UCB HSCT for Heme Malignancies

Acute Lymphoblastic LeukemiaAcute Myelogenous LeukemiaBiphenotypic Leukemia+15 more
Terminated
NCT00177047Phase 2/3PrincipalInvestigator

Autologous Transplant for Multiple Myeloma

Multiple Myeloma
Completed
NCT01163201Phase 1/2PrincipalInvestigator

T-Regulatory Cell and CD3 Depleted Double Umbilical Cord Blood Transplantation in Hematologic Malignancies

Acute Lymphocytic LeukemiaAcute Myeloid LeukemiaAnemia, Refractory, With Excess of Blasts+14 more
Withdrawn

All 3 trials loaded